We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PHCUF market cap is 161.28M. The company's latest EPS is NOK -2.6509 and P/E is -2.24.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Revenue | 173.24M | 213.91M | 256.48M | 354.12M | 374.47M |
| Operating Income | -37.9M | 42.74M | -36.06M | -5.83M | -49M |
| Net Income | -36.71M | 31.83M | -22.4M | -30.9M | -71.86M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Assets | 231.2M | 257.35M | 776.05M | 789.65M | 719.03M |
| Total Liabilities | 54.85M | 48.76M | 267.92M | 287.02M | 256.3M |
| Total Equity | 176.34M | 208.59M | 508.13M | 502.63M | 462.73M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Operating | -24.12M | 20.66M | 15.59M | 23.89M | -2.02M |
| Investing | -1.06M | 610k | -166.21M | -1.9M | -1.46M |
| Financing | 2.65M | -2.78M | 360.19M | -33.98M | -51.34M |
| Market Cap | 161.28M |
| Price to Earnings Ratio | -2.24 |
| Price to Sales Ratio | 0.43 |
| Price to Cash Ratio | 4.76 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 27.11M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 22.68% |
| 52 Week High | 6.50 |
| 52 Week Low | 4.71 |
| Spread (Intraday) | 1 (16.86%) |
| Company Name | Photocure ASA (PK) |
| Address |
hoffsveien 4 oslo 0275 |
| Website | https://www.photocure.com |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
